Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of the tumors

Details for Australian Patent Application No. 2003200201 (hide)

Owner Aventis Pharma S.A. Institut National De La Sante Et De La Recherche Medicale

Inventors Yeh, Patrice; Legrand, Yves; Griscelli, Frank; Li, Hong; Opolon, Paule; Ragot, Thierry; Soria, Jeanette; Perricaudet, Michel; Lu, He; Soria, Claudine; Mabilat, Christelle

Agent Davies Collison Cave

Pub. Number AU-A-2003200201

Parent 753781

Filing date 20 January 2003

Wipo publication date 10 April 2003

International Classifications

C12N 015/57 Mutation or genetic engineering - acting on peptide bonds (3.4)

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/58 Mutation or genetic engineering

Event Publications

6 February 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2003200201

21 December 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200202-Apparatus and method for analysing and mapping soil land terrain

2003200200-Safety blood collection needle assembly